Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) project.
Rodolfo HurlePaolo CasaleAlberto SaitaPiergiuseppe ColomboGrazia Maria ElefanteGiovanni LughezzaniVittorio FasuloMarco PaciottiLuigi DomanicoGiulio BevilacquaDavide MaffeiPietro DianaNicola FregoMaria Teresa SandriFederica MauraEmanuela MorenghiNicolò M BuffiGiorgio GuazzoniMassimo LazzeriPublished in: World journal of urology (2019)
Xpert BC Monitor seems to be a reliable assay, which might avoid unnecessary cystoscopies without missing HG NMIBC when its cutoff is optimized for the AS setting.